机译:Cimpact-现在更新3:“弥漫性星形胶质细胞胶质瘤,IDH-Wildtype,IDH-Wildtype,胶质母细胞瘤的分子特征的推荐诊断标准
Northwestern Univ Dept Pathol Robert H Lurie Canc Ctr Feinberg Sch Med Ward Bldg 3-140 303 E;
NCI Pathol Lab Ctr Canc Res Bldg 10 Bethesda MD 20892 USA;
Univ Utah Huntsman Canc Ctr Dept Neurosurg Salt Lake City UT USA;
Univ Washington Fred Hutchinson Canc Ctr Dept Neurosurg Seattle WA 98195 USA;
Harvard Med Sch Massachusetts Gen Hosp Dept Pathol Boston MA USA;
Mayo Clin Dept Lab Med &
Pathol Rochester MN USA;
Univ Colorado Sch Med Dept Pathol Aurora CO USA;
Univ Calif San Francisco Dept Pathol San Francisco CA 94140 USA;
Heinrich Heine Univ Dept Neuropathol Dusseldorf Germany;
Northwestern Univ Feinberg Sch Med Malnati Brain Tumor Inst Robert H Lurie Canc Ctr Chicago IL;
Heidelberg Univ Inst Pathol Dept Neuropathol Heidelberg Germany;
Univ Hosp Dept Neurol Zurich Switzerland;
机译:Cimpact-现在更新3:“弥漫性星形胶质细胞胶质瘤,IDH-Wildtype,IDH-Wildtype,胶质母细胞瘤的分子特征的推荐诊断标准
机译:IDH-Wildtype glioblastomas和III级/ IV型IDH-突变体Gliomas显示出成纤维细胞活化蛋白特异性PET / CT的升高的示踪剂吸收
机译:IDH-Wildtype较低级弥漫性Gliomas:组织学级和预后分层的分子评估的重要性
机译:弥漫性星形胶质细胞胶质瘤IDH1 / 2野生型胶质瘤的存活具有胶质母细胞瘤的分子特征级IV级:CIPPACT-ock的确认标准
机译:颗粒细胞星形细胞瘤:具有初级胶质母细胞瘤的分子遗传特征的侵袭性IDH-野生型弥漫性胶质瘤